These findings were absent when viral infected cells were treated with ephrin A2 blocker or ephrin A2 silencing RNA (siRNA), thus, confirming the role of ephrin A1/A2 in dysregulated immune response observed in CRS patients (31). This evidence concerns the gene EFNA2 and congenital rubella syndrome.